BlackRock’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.4M | Sell |
3,129,494
-22,241
| -0.7% | -$251K | ﹤0.01% | 2630 |
|
|
2025
Q1 | $36.4M | Buy |
3,151,735
+287,739
| +10% | +$3.32M | ﹤0.01% | 2532 |
|
|
2024
Q4 | $24.3M | Sell |
2,863,996
-198,323
| -6% | -$1.68M | ﹤0.01% | 2883 |
|
|
2024
Q3 | $35.5M | Buy |
3,062,319
+117,203
| +4% | +$1.36M | ﹤0.01% | 2643 |
|
|
2024
Q2 | $34.7M | Buy |
2,945,116
+512,882
| +21% | +$6.04M | ﹤0.01% | 2603 |
|
|
2024
Q1 | $28.8M | Buy |
2,432,234
+190,209
| +8% | +$2.26M | ﹤0.01% | 2729 |
|
|
2023
Q4 | $27.5M | Buy |
2,242,025
+597,278
| +36% | +$7.32M | ﹤0.01% | 2775 |
|
|
2023
Q3 | $15.8M | Buy |
1,644,747
+45,009
| +3% | +$433K | ﹤0.01% | 3025 |
|
|
2023
Q2 | $14.4M | Buy |
1,599,738
+41,604
| +3% | +$374K | ﹤0.01% | 3159 |
|
|
2023
Q1 | $12.2M | Sell |
1,558,134
-14,287
| -0.9% | -$112K | ﹤0.01% | 3136 |
|
|
2022
Q4 | $10.6M | Sell |
1,572,421
-133,727
| -8% | -$904K | ﹤0.01% | 3306 |
|
|
2022
Q3 | $24.8M | Buy |
1,706,148
+34,653
| +2% | +$503K | ﹤0.01% | 2875 |
|
|
2022
Q2 | $16.4M | Buy |
1,671,495
+127,468
| +8% | +$1.25M | ﹤0.01% | 3126 |
|
|
2022
Q1 | $22.8M | Buy |
1,544,027
+39,407
| +3% | +$581K | ﹤0.01% | 3027 |
|
|
2021
Q4 | $19.9M | Buy |
1,504,620
+87,978
| +6% | +$1.16M | ﹤0.01% | 3218 |
|
|
2021
Q3 | $24.7M | Sell |
1,416,642
-9,780
| -0.7% | -$171K | ﹤0.01% | 3097 |
|
|
2021
Q2 | $34.2M | Sell |
1,426,422
-133,066
| -9% | -$3.19M | ﹤0.01% | 2906 |
|
|
2021
Q1 | $40.1M | Buy |
1,559,488
+446,108
| +40% | +$11.5M | ﹤0.01% | 2729 |
|
|
2020
Q4 | $21.1M | Buy |
1,113,380
+198,646
| +22% | +$3.77M | ﹤0.01% | 2912 |
|
|
2020
Q3 | $11.5M | Sell |
914,734
-9,117
| -1% | -$115K | ﹤0.01% | 3071 |
|
|
2020
Q2 | $11.2M | Buy |
923,851
+51,394
| +6% | +$622K | ﹤0.01% | 3059 |
|
|
2020
Q1 | $6.67M | Buy |
872,457
+11,824
| +1% | +$90.5K | ﹤0.01% | 3157 |
|
|
2019
Q4 | $15.3M | Buy |
860,633
+94,121
| +12% | +$1.68M | ﹤0.01% | 2987 |
|
|
2019
Q3 | $8.89M | Buy |
766,512
+29,730
| +4% | +$345K | ﹤0.01% | 3233 |
|
|
2019
Q2 | $16.3M | Buy |
736,782
+666,525
| +949% | +$14.8M | ﹤0.01% | 2930 |
|
|
2019
Q1 | $2.01M | Buy |
70,257
+25,179
| +56% | +$721K | ﹤0.01% | 3660 |
|
|
2018
Q4 | $891K | Buy |
45,078
+25,769
| +133% | +$509K | ﹤0.01% | 3884 |
|
|
2018
Q3 | $427K | Buy |
19,309
+3,104
| +19% | +$68.6K | ﹤0.01% | 4096 |
|
|
2018
Q2 | $132K | Buy |
16,205
+10,871
| +204% | +$88.6K | ﹤0.01% | 4353 |
|
|
2018
Q1 | $50K | Buy |
5,334
+368
| +7% | +$3.45K | ﹤0.01% | 4383 |
|
|
2017
Q4 | $49K | Buy |
4,966
+236
| +5% | +$2.33K | ﹤0.01% | 4380 |
|
|
2017
Q3 | $32K | Buy |
4,730
+399
| +9% | +$2.7K | ﹤0.01% | 4459 |
|
|
2017
Q2 | $32K | Buy |
4,331
+913
| +27% | +$6.75K | ﹤0.01% | 4515 |
|
|
2017
Q1 | $27K | Buy |
+3,418
| New | +$27K | ﹤0.01% | 4497 |
|